SCHEMBL19735300

SCHEMBL19735300

CC(C)(C)c1ccc2c(c1)c1cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)n3)ccc1n2-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.42
▸ KMT2A Q03164 9/20 0.42
▸ ALDH1A1 P00352 7/20 0.42
▸ MAPT P10636 7/20 0.42
▸ HPGD P15428 6/20 0.42
▸ NTSR1 P30989 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.41
▸ NPSR1 Q6W5P4 2/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ LMNA P02545 3/20 0.41
▸ GLA P06280 1/20 0.41
▸ ABCG2 Q9UNQ0 2/20 0.41
▸ MAPK1 P28482 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ ADORA2A P29274 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19735302 0.96 MAPT (0.40) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22065500 0.95 MEN1 (0.44) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL8400448 0.92 MEN1 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19735305 0.91 ABCG2 (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6375179 0.89 MAPT (0.43) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL21515497 0.89 MAPT (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL30107770 0.89 ABCG2 (0.41) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22065079 0.88 ABCG2 (0.45) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL15832251 0.88 RXRA (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL6373323 0.88 ABCG2 (0.42) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 — — US disclosed
US-9960357-B2 Spiro-type compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2018-05-01 — — US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 — — US disclosed
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2017-12-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170365787-A1 SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, NR2E3, LEF1 MEN1 426/4885KMT2A 1141/4885ALDH1A1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback